Disclosures for "Serum BAFF Level Informs Risk of Hypogammaglobulinemia in Patients with Multiple Sclerosis on Ocrelizumab"
-
Dr. Chumakova has nothing to disclose.
-
Dr. Thai has nothing to disclose.
-
Dr. Demetriou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Demetriou has stock in GlyTR Therapeutics. Dr. Demetriou has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Fleming, M.D. has nothing to disclose.
-
Dr. Saxena has nothing to disclose.
-
Dr. Sy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Sy has received intellectual property interests from a discovery or technology relating to health care.